Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia BLOOD Carpenter, P. A., Johnston, L., Fernandez, H. F., Radich, J. P., Mauro, M. J., Flowers, M. D., Martin, P. J., Gooley, T. A. 2017; 130 (9): 1170–72

View details for PubMedID 28698203